Dyadic International, Inc.

NASDAQ:DYAI

1.24 (USD) • At close September 13, 2024
Bedrijfsnaam Dyadic International, Inc.
Symbool DYAI
Munteenheid USD
Prijs 1.24
Beurswaarde 36,552,224
Dividendpercentage 0%
52-weken bereik 1.13 - 2.67
Industrie Biotechnology
Sector Healthcare
CEO Mr. Mark A. Emalfarb
Website https://www.dyadic.com

An error occurred while fetching data.

Over Dyadic International, Inc.

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs,

Vergelijkbare Aandelen

Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc.

ACHV

4.53 USD

Lantern Pharma Inc. logo

Lantern Pharma Inc.

LTRN

4.02 USD

BioVie Inc. logo

BioVie Inc.

BIVI

3.16 USD

CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc.

CASI

7.17 USD

Entera Bio Ltd. logo

Entera Bio Ltd.

ENTX

1.99 USD

SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

SLS

1.32 USD

Seelos Therapeutics, Inc. logo

Seelos Therapeutics, Inc.

SEEL

0.199 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)